Actually, CD4/CD8 ratio was a sensitive and stable marker of anti-tumor cellular immunity (Yang et al. 2016) and a higher CD4/CD8 ratio was related to better distant metastasis-free survival in patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy (Tao et al. 2016). This evidence concerns the gene CD4 and neoplasm.